A new ESVAC report is available, and show an encouraging 15% decrease in sales of veterinary antibiotics in Europe. These sales data are collected annually as part of the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project, which is a cooperation between the national authorities throughout the European Union (EU) and is coordinated by EMA.
These latest figures, which suggest a positive trend in terms of the responsible use of antibiotics in animals in Europe, are highly welcome,” explains David Mackay, the Head of the EMA’s Division on Veterinary Medicines. “However, the report also shows that there is scope for further decrease. Measures to promote the rational use of antibiotics in animals need to continue as part of the European Commission’s action plan against antimicrobial resistance.”
The ESVAC project was launched in April 2010 by EMA following a request from the European Commission to develop a harmonised approach to the collection and reporting of data from EU Member States on the use of antimicrobials in animals. Since the start of the project, the number of countries providing data has continuously increased.